The Vanguard Group Discloses Interest in Spire Healthcare Group

On February 25, 2026, The Vanguard Group, Inc. disclosed its position in Spire Healthcare Group plc, under Rule 8.3 of the Takeover Code. This disclosure followed its acquisition of 1% or more of the relevant securities of Spire Healthcare. Vanguard reported an interest in 14,521,138 ordinary shares of Spire Healthcare, representing 3.61% of the total.

The transaction details reveal that Vanguard purchased 2,320 shares at a unit price of 1.96 GBP. There are no cash-settled or stock-settled derivatives linked to this acquisition. Additionally, no indemnity arrangements or other agreements related to this transaction have been declared.

Vanguard's disclosure is in compliance with regulatory requirements for substantial shareholding disclosures. There are no supplemental forms attached to this disclosure.